Back to profile

profile_subnav_contactperson - PJ (Paul) Wichgers Schreur MSc

type_page

• Antigen discovery and presentation

  Wageningen Bioveterinary Research (WBVR) is involved in vaccine development projects for specific pathogens in close collaboration with public and...

• Rift Valley fever

  Rift Valley fever (RVF) is a viral zoonosis that primarily affects animals but also has the capacity to infect humans. Wageningen Bioveterinary...

• Crimean Congo haemorrhagic fever

  Crimean Congo haemorrhagic fever virus (CCHFV) is a bunya virus transmitted from animals to humans via ticks. In humans, the virus can cause serious...

News

• 

  Promising first results in human clinical trial of Rift Valley fever vaccine

  30 juli 2024 | Promising first results in human clinical trial of Rift Valley fever vaccine - WUR News Promising first results in human clinical trial of Rift Valley...
• 

  WBVR awarded with 25 million CEPI grant for Rift Valley fever vaccine research

  10 oktober 2023 | The Coalition for Epidemic Preparedness Innovations (CEPI) is expanding its partnership with Wageningen Bioveterinary Research (WBVR, part of...
• 

  Novel Rift Valley fever vaccine dosed in Phase I human trial

  18 augustus 2022 | The first healthy volunteer was dosed with hRVFV-4s, a novel live-attenuated Rift Valley fever vaccine. A clinical trial, run by the LARISSA...
• 

  New vaccine against Rift Valley fever is safe and effective in pregnant sheep

  27 januari 2021 | A study by Wageningen Bioveterinary Research (WBVR), in collaboration with BunyaVax and Ceva Animal Health, shows that a new live-attenuated candidate...
• 

  Synthetic antibodies built with bacterial superglue could help fight emerging viruses

  29 april 2020 | Synthetic antibodies constructed using bacterial superglue can neutralise potentially lethal viruses, according to a study published last week in...

• 1
• 2
• Next